Dou HJ - Search Results

1

Different Role of PET-CT Evaluation in Newly Diagnosed Follicular Lymphoma Upon Rituximab-Based Chemotherapy and Chemo-Free Immunotherapy.

Wang N, Huang XY, Jiang XF, Wang L, Cheng S, Xu PP, Dong L, Ou-Yang BS, Mu RJ, Li C, Zhao Y, Feng Y, Dou HJ, Zheng Z, Zhao WL. Wang N, et al. Among authors: dou hj. Hematol Oncol. 2025 Jan;43(1):e70012. doi: 10.1002/hon.70012. Hematol Oncol. 2025. PMID: 39716437 Free PMC article.

2

Therapeutic targeting miR130b counteracts diffuse large B-cell lymphoma progression via OX40/OX40L-mediated interaction with Th17 cells.

Sun R, Zhang PP, Weng XQ, Gao XD, Huang CX, Wang L, Hu XX, Xu PP, Cheng L, Jiang L, Fu D, Qu B, Zhao Y, Feng Y, Dou HJ, Zheng Z, Zhao WL. Sun R, et al. Among authors: dou hj. Signal Transduct Target Ther. 2022 Mar 18;7(1):80. doi: 10.1038/s41392-022-00895-2. Signal Transduct Target Ther. 2022. PMID: 35301282 Free PMC article.

3

CD47 overexpression is related to tumour-associated macrophage infiltration and diffuse large B-cell lymphoma progression.

Shen YG, Ji MM, Yi HM, Shen R, Fu D, Cheng S, Huang CX, Wang L, Xu PP, Dou HJ, Zhao WL. Shen YG, et al. Among authors: dou hj. Clin Transl Med. 2024 Jan;14(1):e1532. doi: 10.1002/ctm2.1532. Clin Transl Med. 2024. PMID: 38193627 Free PMC article. No abstract available.

4

Doxorubicin-loaded dextran-based nano-carriers for highly efficient inhibition of lymphoma cell growth and synchronous reduction of cardiac toxicity.

Fang Y, Wang H, Dou HJ, Fan X, Fei XC, Wang L, Cheng S, Janin A, Wang L, Zhao WL. Fang Y, et al. Among authors: dou hj. Int J Nanomedicine. 2018 Sep 24;13:5673-5683. doi: 10.2147/IJN.S161203. eCollection 2018. Int J Nanomedicine. 2018. PMID: 30288040 Free PMC article.

5

Obstacles impeding the development of nanocarriers for anticancer drugs.

Liu L, Dou H. Liu L, et al. Nanomedicine (Lond). 2021 Jul;16(17):1447-1450. doi: 10.2217/nnm-2021-0101. Epub 2021 Jun 18. Nanomedicine (Lond). 2021. PMID: 34142559 No abstract available.

6

Scalable dextran-polypyrrole nano-assemblies with photothermal/photoacoustic dual capabilities and enhanced biocompatibility.

Huang W, Leng T, Gao M, Hu Q, Liu L, Dou H. Huang W, et al. Carbohydr Polym. 2020 Aug 1;241:116224. doi: 10.1016/j.carbpol.2020.116224. Epub 2020 Apr 28. Carbohydr Polym. 2020. PMID: 32507183

7

Acid-Responsive Decomposable Nanomedicine Based on Zeolitic Imidazolate Frameworks for Near-Infrared Fluorescence Imaging/Chemotherapy Combined Tumor Theranostics.

Guo H, Mukwaya V, Wu D, Xiong S, Dou H. Guo H, et al. Pharmaceutics. 2024 Jun 18;16(6):823. doi: 10.3390/pharmaceutics16060823. Pharmaceutics. 2024. PMID: 38931943 Free PMC article.

8

Cell Coding Arrays Based on Fluorescent Glycan Nanoparticles for Cell Line Identification and Cell Contamination Evaluation.

Cheng M, Liu L, Zhang P, Xiong S, Dou H. Cheng M, et al. ACS Appl Mater Interfaces. 2021 Sep 22;13(37):44054-44064. doi: 10.1021/acsami.1c12674. Epub 2021 Sep 9. ACS Appl Mater Interfaces. 2021. PMID: 34499479

9

Multidimensional Quantitative Measurement of Cancer Chemoresistance through Differential ZIF-8 Nanoparticle Cellular Retention.

Liu L, Cheng M, Guo H, Guan Q, You J, Dou H. Liu L, et al. ACS Appl Mater Interfaces. 2022 Nov 23;14(46):51798-51807. doi: 10.1021/acsami.2c17692. Epub 2022 Nov 11. ACS Appl Mater Interfaces. 2022. PMID: 36367515

10

Enhanced Intracellular Reactive Oxygen Species by Photodynamic Therapy Effectively Promotes Chemoresistant Cell Death.

Xu X, Wang C, Zhang P, Gao X, Guan W, Wang F, Li X, Yuan J, Dou H, Xu G. Xu X, et al. Int J Biol Sci. 2022 Jan 1;18(1):374-385. doi: 10.7150/ijbs.66602. eCollection 2022. Int J Biol Sci. 2022. PMID: 34975339 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

65 results

Search Page

Filters